Expert opinion option 1
Join Dr Joslyn Kirby, an expert in dermatology, and learn about the latest insights in hidradenitis suppurativa (HS). Discover:
- The impact, progression, and pathophysiology of HS
- Unmet needs in HS diagnosis and treatment
- Treatment options and the evolving treatment landscape
Developed by EPG Health for Medthority in collaboration with Novartis Pharma AG, with content provided by Novartis Pharma AG. The views presented in the videos are those of the presenters and not necessarily those of the industry sponsor, Novartis Pharma AG. Any data on non- Novartis products are based on publicly available information at the time of content update. Prescribing information may vary depending on local health authority approval in each country. Before prescribing any product, always refer to the SmPC or product information approved in your local country. Time2DoMore is a trademark owned by Novartis Pharma AG. Following codes supersede any other material reference number appearing on the assets: GLEM/GAL/0072, 75, 79, 84, 99. Diabetes Clinical Trials: Date of preparation August 2020 GLEM/GAL/0115 and December 2020 FUSE code: 19416. Hypertension Guidelines Slide Deck - FUSE MLR number: 111312.